1. Home
  2. CABA vs RCKY Comparison

CABA vs RCKY Comparison

Compare CABA & RCKY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cabaletta Bio Inc.

CABA

Cabaletta Bio Inc.

HOLD

Current Price

$3.67

Market Cap

319.6M

Sector

Health Care

ML Signal

HOLD

Logo Rocky Brands Inc.

RCKY

Rocky Brands Inc.

HOLD

Current Price

$39.23

Market Cap

273.7M

ML Signal

HOLD

Company Overview

Basic Information
Metric
CABA
RCKY
Founded
2017
1932
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Shoe Manufacturing
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
319.6M
273.7M
IPO Year
2019
1996

Fundamental Metrics

Financial Performance
Metric
CABA
RCKY
Price
$3.67
$39.23
Analyst Decision
Strong Buy
Buy
Analyst Count
6
1
Target Price
$14.50
$40.00
AVG Volume (30 Days)
5.1M
55.7K
Earning Date
05-14-2026
04-28-2026
Dividend Yield
N/A
1.71%
EPS Growth
10.26
94.74
EPS
N/A
0.17
Revenue
N/A
$270,408,000.00
Revenue This Year
N/A
$8.12
Revenue Next Year
N/A
$4.90
P/E Ratio
N/A
$226.62
Revenue Growth
N/A
N/A
52 Week Low
$1.26
$20.69
52 Week High
$4.23
$48.70

Technical Indicators

Market Signals
Indicator
CABA
RCKY
Relative Strength Index (RSI) 55.61 57.18
Support Level $2.11 $37.31
Resistance Level $3.73 $44.83
Average True Range (ATR) 0.24 1.44
MACD 0.01 0.66
Stochastic Oscillator 61.41 93.28

Price Performance

Historical Comparison
CABA
RCKY

About CABA Cabaletta Bio Inc.

Cabaletta Bio Inc is a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies and exploring their potential to provide a deep and durable, perhaps curative, treatment for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes Chimeric AutoAntibody Receptor, or CAART cells, that are designed to selectively bind and eliminate only specific B cells that produce disease-causing autoantibodies, or pathogenic B cells, while sparing normal B cells. Its CABA platform encompasses two strategies: CARTA (chimeric antigen receptor T cells for autoimmunity) and CAART (chimeric autoantibody T cells) that have the potential to be applied across a broad range of autoimmune diseases.

About RCKY Rocky Brands Inc.

Rocky Brands Inc is a designer, manufacturer, and marketer of premium footwear and apparel under brands such as Muck, XTRATUF, Rocky, Durango, Georgia Boot, Lehigh, Ranger, and the licensed brand Michelin. The company operates through three segments, with the wholesale segment generating the majority of revenue through sales of footwear and accessories to sporting goods stores, outdoor specialty stores, online retailers, marine stores, independent retailers, mass merchants, retail uniform stores, and specialty safety shoe stores. The retail segment focuses on direct-to-consumer sales through e-commerce platforms and company-operated stores, while the contract manufacturing segment includes sales to the U.S. military, private label production, and sourcing arrangements for customers.

Share on Social Networks: